Investor (INVE) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
2 Feb, 2026Executive summary
Adjusted net asset value grew 2% in Q3 2024 to SEK 986.3 billion, reaching an all-time high, with a five-year average annual growth of 19% including dividends.
Total shareholder return was 8% in Q3, outperforming the SIXRX index's 4%; year-to-date, listed companies delivered a 23% TSR.
Major subsidiaries achieved 7% organic sales growth and 8% adjusted operating income/EBITA growth year-over-year.
SEK 1.9 billion in add-on acquisitions completed, supporting long-term competitiveness, with significant deals in Piab Group and Sarnova.
The market environment remains challenging with high competition and macroeconomic uncertainty, but opportunities exist in innovation and acquisitions.
Financial highlights
Net sales for Q3 2024 were SEK 15,733 million; for 9M 2024: SEK 46,809 million.
Group LTM sales and EBITDA, including 40% in Tre, were SEK 66 billion and SEK 16 billion, respectively.
Result per share Q3 2024: SEK 4.18; 9M 2024: SEK 47.35.
Total return on the share was 36% for 9M 2024, with 8% in Q3.
Dividends from listed companies amounted to SEK 12,548 million during 9M 2024.
Outlook and guidance
Continued focus on profitable growth, efficiency, innovation, and strategic add-on acquisitions to drive long-term value.
Add-on acquisitions remain a strategic priority, with recent deals in China and the US to strengthen Piab Group.
No specific guidance on future growth rates, but optimism for continued growth in key products and segments.
Latest events from Investor
- NAV up 8% in Q2, 9% TSR, strong listed returns, robust M&A in Patricia Industries.INVE
Q2 20243 Feb 2026 - Net asset value up 14% to SEK 1,087bn, 15% return, and 8% dividend hike; leverage at 2.1%.INVE
Q4 202522 Jan 2026 - NAV up 20% to SEK 970bn, TSR 27%, dividend raised to SEK 5.20/share.INVE
Q4 20249 Jan 2026 - Q1 2025 saw a 3% NAV drop, 2% shareholder return, and a major life sciences acquisition.INVE
Q1 202521 Dec 2025 - NAV up 3% in Q2, but total shareholder return fell 5% as Patricia Industries underperformed.INVE
Q2 20255 Nov 2025 - Q3 2025 saw 7% NAV growth, 5% shareholder return, and major strategic acquisitions.INVE
Q3 202520 Oct 2025